Table 4 Comparison of the main adverse events and antithrombotic therapy according to the region of CMBs
Region of CMBs | χ2 | P value | |||
|---|---|---|---|---|---|
Brain lobe n = 42 | Deep brain tissue n = 50 | Mixed region n = 18 | |||
Antithrombotic therapy | |||||
Anticoagulant therapy (%) | 20 (47.6) | 20 (40.0) | 14 (77.8) | 7.617 | 0.022 |
Antiplatelet therapy (%) | 22 (52.4) | 30 (60.0) | 4 (32.2) | ||
CH events (%) | 8 (19.0) | 6 (12.0) | 4 (22.2) | 1.368 | 0.505 |
All-cause death (%) | 2 (4.8) | 8 (16.0) | 4 (22.2) | 4.342 | 0.114 |